Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

President Biden unveils initiative to boost COVID-19 vaccination numbers

By Brian Buntz | July 7, 2021

Joe Biden

President Joe Biden poses for his official portrait Wednesday, March 3, 2021, in the Library of the White House. (Official White House Photo by Adam Schultz)

With new cases of COVID-19 increasing 14% in the past two weeks, President Biden is aiming to convince unvaccinated Americans to get their first dose of the vaccine.

CDC data show that the highly transmissible Delta variant now dominates the U.S., driving close to 52% of COVID-19 cases in the U.S. from June 19 to July 13, according to CDC. Meanwhile, the Alpha variant that first emerged in the U.K. caused 29% of U.S. COVID-19 infections.

“More than 182 million Americans have received at least one shot, including nearly 90% of seniors and 70% of adults over the age of 27,” Biden said in remarks yesterday about the COVID-19 response and the vaccination program.

The U.S. is on the cusp of having 160 million fully vaccinated Americans, he added. Yet, only about three million Americans were vaccinated at the beginning of Biden’s term.

“If you are vaccinated, you’re protected. But if you’re unvaccinated, you’re not, and you’re putting yourself and — more importantly from your perspective — your family and friends at risk,” Biden said.

For the remainder of the summer, Biden said the U.S would reduce reliance on mass vaccination sites while supporting walk-in vaccination in pharmacies, worksites, primary care doctors, pediatrician clinics, mobile clinics and other locations. “Now we need to go from community to community, neighborhood by neighborhood and ofttimes door to door,” Biden said.

To inspire more people to get vaccinated, the government will launch a door-to-door educational initiative.

The U.S. will also launch surge response teams in response to burgeoning COVID-19 hotspots.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer logo
Pfizer recalls certain lots of blood-pressure drug Accupril
FDA clears antibiotic-embedded hernia mesh for fighting implant infections
Roche/Novartis
Roche finalizes repurchase of shares from Novartis
coronavirus COVID-19 Pfizer
7 core strategies in Biden’s battle against COVID-19

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards